Transcept Pharmaceuticals Resubmits Intermezzo New Drug Application

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval of Intermezzo® for use as needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep. Transcept expects that the Intermezzo® NDA resubmission, if accepted and deemed complete by the FDA, will be subject to a Class 2 six-month review.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!